FDA approval for Tabrecta in metastatic non-small cell lung cancer with METex14
May 7, 2020Sales and Marketing Incyte, Novartis, Tabrecta, pharma
The FDA has awarded marketing authorisation to Novartis for the Oral MET inhibitor Tabrecta (capmatinib) for the first-line treatment of metastatic non-small …
UK becomes first European country to pass 30,000 deaths from COVID-19
May 7, 2020Business Services COVID-19, coronavirus
Britain has become the first European nation to pass 30,000 deaths from the coronavirus, putting it only behind the US as …
Scientists in the UK and US identify hundreds of mutations in the COVID-19 virus
May 7, 2020Business Services COVID-19, Protein, coronavirus, virus
Two studies from the UK and US have identified hundreds of mutations in COVID-19, which could cause problems for the …
South Korea says Ebola drug remdesivir may not be suitable for all coronavirus patients
May 6, 2020Research and Development COVID-19, coronavirus, south korea
South Korea says that remdesivir, traditionally used in treating Ebola, may not be effective enough in treating COVID-19 patients. South …
AZ’s Farxiga becomes first FDA-approved SGLT2 inhibitor for heart failure with reduced ejection fraction
May 6, 2020Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, heart failure
The FDA has moved to approve an oral tablet formulation of AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular …
Portola Pharmaceuticals to merge with Alexion in $1.41bn cash deal
May 6, 2020Research and Development, Sales and Marketing Alexion, Portola Pharmaceuticals, pharma
Alexion has announced it is to acquire Boston-based blood disorder specialist Portola Pharmaceuticals in a transaction to the value of …
Pharmafile.com’s weekly COVID-19 news round-up
May 6, 2020Research and Development COVID-19, coronavirus
Vaccines and treatments for COVID-19 continue to dominate the news, as two studies reveal “positive” data for Gilead’s remdesivir in …
Ousted chief of BARDA says Trump administration ignored COVID-19 warnings
May 6, 2020Research and Development BARDA, COVID-19, chloroquine, coronavirus, hydroxychloroquine
Ousted Director of the Biomedical Advanced Research and Development Authority (BARDA), Dr Rick Bright, alleges the Trump administration ignored warnings …
Jonathan Freve joins Galecto as Chief Financial Officer
May 5, 2020Manufacturing and Production
The biotech company Galecto Inc have appointed Jonathan Freve as its Chief Financial Officer, and in his role he will …
First French case of COVID-19 occurred in December, a month earlier than previously thought
May 5, 2020Manufacturing and Production COVID-19, coronavirus
A French patient who suffered from pneumonia in December actually had COVID-19, it has been revealed. Dr Yves Cohen, the …
Scientists in Kenya discover microbe that could stop transmission of malaria
May 5, 2020Manufacturing and Production malaria, mosquitoes
Researchers studying malaria in Kenya have discovered a microbe that blocks transmission of malaria from mosquitoes which could pave the …
MHRA launches new pharmacovigilance reporting platform for COVID-19 treatments
May 5, 2020Manufacturing and Production, Research and Development COVID-19, MHRA, UK, coronavirus, pharma
A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agency’s (MHRA) to track potential …
UK contact-tracing app being tested on the Isle of Wight
May 5, 2020Manufacturing and Production COVID-19, coronavirus
The NHS’s coronavirus contract tracing app has been published to Apple and Google’s app stores with council staff and healthcare …
Sanofi and Regeneron’s Libtayo shows durable responses in world’s most common skin cancer
May 5, 2020Manufacturing and Production, Research and Development Cancer, Libtayo, Regeneron, Sanofi
Sanofi and Regeneron’s have lifted the lid on new topline data on their PD-1 inhibitor Libtayo (cemiplimab) in patients with …
Working Life Interview: Kim Stratton, CEO, Orphazyme
May 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Orphazyme, Working Life
“Every professional faces challenges. As a woman in industry, particularly in leadership, it adds another dimension to those challenges in …
Lonza and Moderna enter agreement to mass produce coronavirus vaccine
May 4, 2020Sales and Marketing COVID-19, coronavirus
Lonza Group AG and Moderna Inc have entered a deal to develop 1 billion doses of coronavirus vaccines a year. …
FDA approves emergency use of Gilead’s remdesivir for hospitalised COVID-19 patients
May 4, 2020Sales and Marketing COVID-19, FDA, Gilead, coronavirus, remdesivir
Gilead’s antiviral therapy remdesivir has shown tentatively promising efficacy in the race to find an effective treatment for COVID-19, one …
Trump vows to reduce America’s reliance on foreign drug imports
May 4, 2020Sales and Marketing COVID-19, coronavirus
President Donald Trump has vowed to cut the US’s reliance on foreign drugs, singling out China and Ireland as countries …
UK testing experimental treatment for use in COVID-19 patients
May 4, 2020Sales and Marketing COVID-19, coronavirus, coronavirus treatment
British scientists are testing an experimental drug to help some of society’s most vulnerable fight off the COVID-19 coronavirus.
Mike Pompeo says there is evidence COVID-19 was made in a lab, despite US intelligence saying it occurred naturally
May 4, 2020Sales and Marketing COVID-19, Wuhan Institute of virology, coronavirus, lab, pandemic
US Secretary of State Mike Pompeo claimed that there is evidence the COVID-19 coronavirus was created in a lab, despite …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
